Verition Fund Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-45,854
| Closed | -$153K | – | 2178 |
|
|
2023
Q4 | $153K | Sell |
45,854
-15,535
| -25% | -$51.7K | ﹤0.01% | 1656 |
|
|
2023
Q3 | $230K | Buy |
61,389
+10,500
| +21% | +$39.3K | ﹤0.01% | 1562 |
|
|
2023
Q2 | $217K | Buy |
50,889
+1,800
| +4% | +$7.69K | ﹤0.01% | 1531 |
|
|
2023
Q1 | $336K | Buy |
+49,089
| New | +$336K | ﹤0.01% | 1334 |
|
|
2022
Q4 | – | Sell |
-10,671
| Closed | -$103K | – | 1773 |
|
|
2022
Q3 | $103K | Buy |
+10,671
| New | +$103K | ﹤0.01% | 2015 |
|